ARCHIVES

Immune Therapy Possible For Metastatic Breast Cancer

This article is from The Cancer Letter archive.

Vol. 27 No. 9 | September 24, 2004

Download PDF Visit The Full Archive

Related Articles

Phase III Trial Of PARP Inhibitor BSI-201 Opens For Triple-Negative Breast Cancer

July 31, 2009

In Brief Yale Cancer Center Begins Reorganization, Names New Deputy Director, Prevention Chief

January 6, 1995

RFA For Patient Compliance Study

September 26, 1980

Bush Signs Bill To Increase Blood Cancer Research.

May 17, 2002

Schmidt Attempted To Answer Critics

October 1, 1976

NCI Toughens Criteria for MERIT Awards

February 23, 1996